DUX4 and facioscapulohumeral muscular dystrophy: We previously evaluated our PAX7 target gene repression biomarker alongside three DUX4 target gene expression biomarkers across seven independent transcriptomic data sets of FSHD muscle biopsies and immortalized cell lines (28).